Evonik Evonik

X

CAS 944835-85-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
2-(1H-Indazol-6-Ylsulfanyl)-N-Methylbenzamide
Also known as: 944835-85-2, 2-((1h-indazol-6-yl)thio)-n-methylbenzamide, Axitinib impurity 8, 2-(1h-indazol-6-ylsulfanyl)-n-methylbenzamide, Benzamide, 2-(1h-indazol-6-ylthio)-n-methyl-, 2-(1h-indazol-6-ylthio)-n-methylbenzamide
Molecular Formula
C15H13N3OS
Molecular Weight
283.4  g/mol
InChI Key
JBFLDDCNCFRBIG-UHFFFAOYSA-N

1 2D Structure

2-(1H-Indazol-6-Ylsulfanyl)-N-Methylbenzamide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(1H-indazol-6-ylsulfanyl)-N-methylbenzamide
2.1.2 InChI
InChI=1S/C15H13N3OS/c1-16-15(19)12-4-2-3-5-14(12)20-11-7-6-10-9-17-18-13(10)8-11/h2-9H,1H3,(H,16,19)(H,17,18)
2.1.3 InChI Key
JBFLDDCNCFRBIG-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C=NN3
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 944835-85-2

2. 2-((1h-indazol-6-yl)thio)-n-methylbenzamide

3. Axitinib Impurity 8

4. 2-(1h-indazol-6-ylsulfanyl)-n-methylbenzamide

5. Benzamide, 2-(1h-indazol-6-ylthio)-n-methyl-

6. 2-(1h-indazol-6-ylthio)-n-methylbenzamide

7. 2-(1h-indazol-6-ylthio)-n-methyl- Benzamide

8. Schembl13446109

9. Mfcd23104312

10. Zinc34639527

11. As-47073

12. F11881

2.3 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 283.4 g/mol
Molecular Formula C15H13N3OS
XLogP32.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass283.07793322 g/mol
Monoisotopic Mass283.07793322 g/mol
Topological Polar Surface Area83.1 Ų
Heavy Atom Count20
Formal Charge0
Complexity352
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
261953-36-0
Axitinib
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY